Category | Financing

Adaptimmune closes its initial public offering of $175.7 million

Posted on 11 May 2015

Adaptimmune announced the closing of its initial public offering of 11,250,000 American Depositary Shares at a price to the public of $17.00 per ADS.

Tags: ,

Series B financing for $90 million for Kymab

Posted on 06 May 2015

Kymab has successfully raised an additional US$50 million to complete a US$90 million Series B financing.

Tags: , ,

Adaptive Biotechnologies Series F financing

Posted on 05 May 2015

Adaptive Biotechnologies announced the completion of Adaptive’s Series F financing round with a $195 million investment to support several strategic growth initiatives.

Tags: ,

Series A financing for $41 million for Symbiomix

Posted on 05 May 2015

Symbiomix Therapeutics announced multiple milestones, including the closing of the third and final tranche of a $41 million Series A financing and positive results from a multi-center, randomized Phase 2 trial testing a single oral dose of SYM-1219 for the treatment of bacterial vaginosis (BV).

Tags: ,

Mirna Therapeutics secures $41.8mn series D

Posted on 05 May 2015

Mirna Therapeutics announced the completion of a $41.8 million Series D financing

Tags:

MyoKardia secures series B for $46 million

Posted on 05 May 2015

MyoKardia announced the successful completion of a $46 million Series B financing

Tags:

Intarcia announces $225 million synthetic royalty deal

Posted on 05 May 2015

Intarcia Therapeutics announced the closing of a $225 million synthetic royalty financing

Tags:

CRISPR Therapeutics gains $64mn in series A and B

Posted on 30 April 2015

CRISPR Therapeutics announced the closing of a Series A and Series B financing totaling USD 64 million

Tags:

GW Pharma brings in $179mn in public offering

Posted on 30 April 2015

GW will issue 1,600,000 American Depositary Shares (“ADSs”), representing 19,200,000 ordinary shares of GW, at a price to the public of $112.00 per ADS on the NASDAQ Global Market

Tags:

Jounce Therapeutics gains series B financing for $56 million

Posted on 28 April 2015

Jounce Therapeutics announced the successful completion of a $56 million oversubscribed Series B financing

Tags: